New pill aims to ease Alzheimer's fog in early stages

NCT ID NCT04602624

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times

Summary

This study tested a drug called SAGE-718 in 26 people with mild memory loss or early Alzheimer's. The main goal was to see if the drug is safe and tolerable, and to check if it helps with thinking, memory, or mood. Participants took the drug and were monitored for side effects and any changes in their symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sage Investigational Site

    Phoenix, Arizona, 85044, United States

  • Sage Investigational Site

    Redlands, California, 92374, United States

  • Sage Investigational Site

    Miami, Florida, 33137, United States

  • Sage Investigational Site

    St. Petersburg, Florida, 33713, United States

  • Sage Investigational Site

    Decatur, Georgia, 30030, United States

  • Sage Investigational Site

    Decatur, Georgia, 30033, United States

  • Sage Investigational Site

    Gaithersburg, Maryland, 20877, United States

  • Sage Investigational Site

    Farmington Hills, Michigan, 48334, United States

  • Sage Investigational Site

    Omaha, Nebraska, 68130, United States

  • Sage Investigational Site

    North Canton, Ohio, 44720, United States

Conditions

Explore the condition pages connected to this study.